Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Alliance Grants

University of Western Ontario

$22,000.00

Development of cost-effective 3D ultrasound imaging systems for pelvic floor imaging _x000d_ _x000d_

FY 2020-21

Summary
Pelvic organ prolapse (POP), a common disorder exclusive to women, is defined as the descent of the pelvic organs into the vaginal cavity. Symptoms of POP, such as pain, bulging sensation, or incontinence, can be alleviated by using pessaries, which are passive medical devices, inserted intra-vaginally to support the pelvic organs. POP affects 12%-50% of the female population and is expected to increase by 45%-200% by 2050. Currently, diagnostic evaluation of prolapse is performed via physical examination. Since the pessaries are fit through trial and error after manual examination, the accuracy of the fit depends on the physician's expertise and the availability of pessary designs. Thus, many patients cannot be successfully fitted with a pessary, and many discontinue pessary treatment due to compilations. There is a need for a quantitative technique for improving the diagnosis and identifying the best pessary fit. Cosm, a medical device start-up in Toronto, is developing a data-driven platform to create a personalized treatment for POP to improve the lives of patients in Canada and abroad. Cosm has developed a novel technique for the use of three-dimensional ultrasound (3D US) to image the vaginal cavity to quantitatively assess prolapse and design custom pessaries. However, commercial 3D US systems are too expensive and difficult to use and incorporate in Cosm's product pipeline. Fenster's lab has invented, developed, and translated multiple 3D US systems into clinical use and to companies. In this system, a 2D US probe is attached to a hand-held motorized scanner, which moves the probe in known motions and acquires 2D US images, which are reconstructed into a 3D US image, significantly reducing the cost of 3D imaging. Our goal is to design, develop, and evaluate a cost-effective 3D US system for pelvic floor imaging. Cosm will obtain regulatory approval for bringing this 3D US system into the market. This project would entail a major milestone for Cosm towards achieving their goal of improving Canadian women's health and reducing the burden of pelvic floor dysfunctions on the health care system.
Program
Alliance Grants
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
561143-2020
Name nom
Fenster, Aaron
Department département
Medical Biophysics
Organization id
36
Institution établissement
University of Western Ontario
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2020
Competition year année de concours
2020
Award amount
22000
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
518
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Medical equipment and apparatus
Area of application fr
Appareils et instruments médicaux
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Installment
inst:1 - 1
Partie
1
Nb partie
1
Application title
Development of cost-effective 3D ultrasound imaging systems for pelvic floor imaging _x000d_ _x000d_
Keyword
NSERC
Application summary
Pelvic organ prolapse (POP), a common disorder exclusive to women, is defined as the descent of the pelvic organs into the vaginal cavity. Symptoms of POP, such as pain, bulging sensation, or incontinence, can be alleviated by using pessaries, which are passive medical devices, inserted intra-vaginally to support the pelvic organs. POP affects 12%-50% of the female population and is expected to increase by 45%-200% by 2050. Currently, diagnostic evaluation of prolapse is performed via physical examination. Since the pessaries are fit through trial and error after manual examination, the accuracy of the fit depends on the physician's expertise and the availability of pessary designs. Thus, many patients cannot be successfully fitted with a pessary, and many discontinue pessary treatment due to compilations. There is a need for a quantitative technique for improving the diagnosis and identifying the best pessary fit. Cosm, a medical device start-up in Toronto, is developing a data-driven platform to create a personalized treatment for POP to improve the lives of patients in Canada and abroad. Cosm has developed a novel technique for the use of three-dimensional ultrasound (3D US) to image the vaginal cavity to quantitatively assess prolapse and design custom pessaries. However, commercial 3D US systems are too expensive and difficult to use and incorporate in Cosm's product pipeline. Fenster's lab has invented, developed, and translated multiple 3D US systems into clinical use and to companies. In this system, a 2D US probe is attached to a hand-held motorized scanner, which moves the probe in known motions and acquires 2D US images, which are reconstructed into a 3D US image, significantly reducing the cost of 3D imaging. Our goal is to design, develop, and evaluate a cost-effective 3D US system for pelvic floor imaging. Cosm will obtain regulatory approval for bringing this 3D US system into the market. This project would entail a major milestone for Cosm towards achieving their goal of improving Canadian women's health and reducing the burden of pelvic floor dysfunctions on the health care system.
University of Western Ontario - $22,000 Grant (2020-2… | Canada Spends